Vimta Labs Limited (VIMTALABS) — Announcement | 20 July 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Vimta Labs reported Q1 FY27 earnings with strong YoY growth in revenue, EBITDA, and PAT.
🔄 What Changed
YoY revenue growth of 11.1%, EBITDA margin expansion to 36.4%, PAT margin improvement to 18.6%
🔮 What's Next
Capacity expansions, service innovations, and market penetration to drive growth
💡 Investor Takeaway
Shareholders gain confidence in Vimta's scalable CRTO model and global revenue diversification.

Vimta Labs presented Q1 FY27 results showing total income of ₹1,129 crores, EBITDA of ₹411 crores with 36.4% margin, and PAT of ₹210 crores at 18.6% margin, reflecting YoY growth of 11.1%, 13.7%, and 16.0% respectively. The presentation outlined strategic growth drivers including market expansion, service innovation, and capacity scaling, while emphasizing compliance and long-term customer partnerships as core strengths. It highlighted international revenue contribution of 40% in pharma analytical services and 75% in clinical research, reinforcing global positioning. The company reaffirmed its leadership in CRTO services across pharma, food, and electronics testing segments, supported by infrastructure investments and regulatory accreditations.

📄 View Original Announcement (PDF)

About Vimta Labs Limited (VIMTALABS)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹2,878.27 Cr P/E: 23.3 ROE: 19.2% ROCE: 24.3% Div Yield: 0.31%

View full VIMTALABS stock details →

📡 Get AI alerts when VIMTALABS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track VIMTALABS — Free

📊 More VIMTALABS filings

See all VIMTALABS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when VIMTALABS files new disclosures

Track VIMTALABS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track VIMTALABS — Free

Free account · 2 AI queries/day